ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 51

$732K Total Retail Price of All Prescriptions

Rank: 5 out of 51

405 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oklahoma
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 405 patients filled at least one prescription for a schedule three drug, compared to an average of 22%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 605 539 83 1 3
FUROSEMIDE 376 338 76 2 5
HYDROCODONE-ACETAMINOPHEN 362 306 103 S3 3 1
LISINOPRIL 301 267 50 4 2
OMEPRAZOLE 297 246 48 5 4
AMLODIPINE BESYLATE 294 282 51 6 9
ATORVASTATIN CALCIUM 273 235 60 7 14
POTASSIUM CHLORIDE 270 265* 59 8 6
SIMVASTATIN 214 187 40 9 8
HYDROCHLOROTHIAZIDE 205 187 43 10 17
METOPROLOL TARTRATE 199 183 45 11 13
CELEBREX 188 163 23 12 67
CLOPIDOGREL 169 154 32 13 19
ENALAPRIL MALEATE 167 147 37 14 76
NEXIUM 166 166 22 15 24
CRESTOR 164 164 23 16 65
CLONIDINE HCL 124 109 32 17 45
CITALOPRAM HBR 123 112 15 18 16
CARVEDILOL 115 100 21 19 40
ALLOPURINOL 115 96 21 19 41
METOPROLOL SUCCINATE 113 113 23 21 23
GABAPENTIN 110 110 18 22 10
NAMENDA 110 110 16 22 22
SERTRALINE HCL 109 104* 17 24 26
QUETIAPINE FUMARATE 100 <11 <11 A 25 51
TRAZODONE HCL 99 94* 22 26 34
DIOVAN 92 87* 16 27 82
SYNTHROID 91 86* 24 28 108
PRADAXA 90 90 11 29 162
DONEPEZIL HCL 89 89 19 30 30
MEGESTROL ACETATE 85 85 26 R 31 128
LORAZEPAM 83 83 17 B 32 37
LANTUS 80 61 11 33 58
METFORMIN HCL ER 75 61 12 34 73
WARFARIN SODIUM 72 67* 15 35 28
HYDROCORTISONE VALERATE 71 66* 26 36 173
TRIAMTERENE-HCTZ 70 70 15 37 92
ZOLPIDEM TARTRATE 69 64* 15 38 20
DIGOXIN 69 69 14 38 106
TRAMADOL HCL 69 64* 23 38 18
TEMAZEPAM 68 57 11 B 41 71
OLANZAPINE 66 <11 <11 A 42 84
ALPRAZOLAM 66 61* 14 B 42 7
BUSPIRONE HCL 65 65 12 44 151
MONTELUKAST SODIUM 65 60* 17 44 64
KLOR-CON 10 64 <11 <11 46 185
TAMSULOSIN HCL 63 63 15 47 33
MIRTAZAPINE 63 <11 <11 47 74
JANUVIA 60 <11 <11 49 78
ESCITALOPRAM OXALATE 59 54* 12 50 55
RISPERIDONE 57 <11 <11 A 51 59
PRAVASTATIN SODIUM 57 57 14 51 25
CYMBALTA 56 <11 <11 53 48
PROPRANOLOL HCL 55 <11 <11 54 95
RANITIDINE HCL 55 50* 15 54 35
KLOR-CON M10 52 <11 <11 56 139
ADVAIR DISKUS 52 47* 14 56 72
DILTIAZEM 24HR CD 51 <11 <11 58 211
CLONAZEPAM 51 <11 <11 B 58 31
GLIMEPIRIDE 50 <11 <11 60 104
NATEGLINIDE 50 <11 <11 60 213
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.